157 filings
Page 7 of 8
8-K
m6f6m27t hg2zr
16 May 16
Biostage Announces $5 Million At-The-Market Offering
12:00am
8-K
puh0rx004r c9ych
12 May 16
Bioengineered Organ Implant Developer Biostage Reports Q1 2016 Results
12:00am
8-K
s67yn
31 Mar 16
Amendments to Articles of Incorporation or Bylaws
12:00am
8-K
0v7p2uag0cyg 7s
24 Mar 16
Departure of Directors or Certain Officers
12:00am
8-K
13o kyp5phs
17 Mar 16
Bioengineered Organ Implant Developer HART Reviews Progress and Q4 2015 Results
12:00am
8-K
h9mxfkk
10 Mar 16
Bioengineered Organ Implant Developer HART Names
12:00am
8-K
ftzbccdlg3zhhqrse3
9 Feb 16
Regulation FD Disclosure
12:00am
8-K
tachlo
7 Jan 16
Other Events
12:00am
8-K
iigji 5w8wt3wgmwi
15 Dec 15
HART Secures Common Stock Purchase Facility with Aspire Capital
12:00am
8-K
v1143
17 Nov 15
Harvard Apparatus Regenerative Technology 2015 Q3 Earnings Call
12:00am
8-K
tdv0ao40jp48hqe1aij
17 Nov 15
Regulation FD Disclosure
12:00am
8-K
hdlho2ce l4
12 Nov 15
HART Reports Q3 Financial Results and Provides Business Update
12:00am
8-K
izyy23tf
10 Nov 15
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
8-K
p31dp9mw
22 Oct 15
Regulation FD Disclosure
12:00am
8-K
b6p3jd08d00sq29s60c0
13 Aug 15
Harvard Apparatus Regenerative Technology Provides Business Update and Reports Second Quarter 2015 Financial Results
12:00am
8-K
zaclw
17 Jul 15
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
8-K
isy8c1jqxo 5du7
6 Jul 15
Harvard Apparatus Regenerative Technology Appoints James McGorry as New Chief Executive Officer
12:00am
8-K
ybc7 c5lgh4hk66vm
26 May 15
Submission of Matters to a Vote of Security Holders
12:00am
8-K
xt2xzbi9r
7 May 15
Harvard Apparatus Regenerative Technology Reports Financial Results for the First Quarter 2015
12:00am
8-K
tm7vh6xakxbsq gw
17 Apr 15
Departure of Directors or Certain Officers
12:00am